Antibiotic Resistance: Advances in Understanding and Drug Development

Pharma's Almanac's David Alvaro, Ph.D., explores the significant challenges presented by the spread of antibiotic resistance and ongoing advances in development and clinical research to develop new, novel antibiotics.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: